ELEDON PHARMACEUTICALS INC's ticker is ELDN and the CUSIP is 28617K101. A total of 31 filers reported holding ELEDON PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.24 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $2,874 | +3.5% | 1,217,882 | 0.0% | 0.19% | +1.6% |
| Q4 2022 | $2,777 | -99.9% | 1,217,882 | -0.5% | 0.19% | -21.2% |
| Q3 2022 | $3,377,000 | +6.1% | 1,223,500 | -6.3% | 0.24% | -2.1% |
| Q2 2022 | $3,184,000 | -38.1% | 1,305,095 | 0.0% | 0.24% | -39.0% |
| Q1 2022 | $5,142,000 | -10.7% | 1,305,095 | 0.0% | 0.40% | +15.5% |
| Q4 2021 | $5,755,000 | -28.6% | 1,305,095 | 0.0% | 0.34% | +4.3% |
| Q3 2021 | $8,065,000 | -28.0% | 1,305,095 | -7.8% | 0.33% | -13.7% |
| Q2 2021 | $11,197,000 | -26.1% | 1,415,500 | 0.0% | 0.38% | +12.8% |
| Q1 2021 | $15,146,000 | – | 1,415,500 | – | 0.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Logos Global Management LP | 1,339,793 | $10,598,000 | 0.89% |
| CM Management, LLC | 75,000 | $593,000 | 0.43% |
| Cormorant Asset Management, LP | 1,415,500 | $11,197,000 | 0.38% |
| BVF INC/IL | 1,113,435 | $8,807,000 | 0.33% |
| Ikarian Capital, LLC | 350,000 | $2,769,000 | 0.22% |
| Woodline Partners LP | 857,445 | $6,782,000 | 0.13% |
| INGALLS & SNYDER LLC | 51,149 | $405,000 | 0.02% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 853,208 | $6,749,000 | 0.01% |
| BOOTHBAY FUND MANAGEMENT, LLC | 40,052 | $317,000 | 0.01% |
| Point72 Asset Management, L.P. | 188,690 | $1,493,000 | 0.01% |